LANGUAGE:
- WHO WE ARE
- What We Do
- Industries
- LAⁱNGUAGE CLOUD™
Our people are our pride, helping companies resonate with their customers for 20+ years.
We create, transform, test, and train more content than anyone in the world – from text, voice, audio, video, to structured & unstructured data.
Solutions
Our experts know the in-and-outs of your industry & its challenges.
Harness the Lionbridge Lainguage Cloud to support your end-to-end localization and content lifecycle
Our people are our pride, helping companies resonate with their customers for 20+ years.
About Us
Key Facts
Leadership
Insights
News
Trust Center
We create, transform, test, and train more content than anyone in the world – from text, voice, audio, video, to structured & unstructured data.
Content Services
Technical Writing
Training & eLearning
Financial Reports
Scientific Articles
Multicultural Marketing
Digital Experience Assessments
Translation Services
Translation
Video Localization
Software Localization
Website Localization
Translation for Regulated Companies
Interpretation
Multilingual SEO & Digital Marketing
Content Optimization
Testing Services
Functional QA & Testing
Compatibility Testing
Interoperability Testing
Performance Testing
Accessibility Testing
UX/CX Testing
Solutions
Machine Translation
Live Events
Our Knowledge Hubs
Machine Translation
Future of Localization
Innovation to Immunity
COVID-19 Resource Center
Disruption Series
Patient Engagement
Lionbridge Insights
Our experts know the in-and-outs of your industry & its challenges.
Life Sciences
Banking & Finance
Retail
E-Commerce
Games
Automotive
Consumer Packed Goods
Technology
Industrial Manufacturing
Legal Services
Travel & Hospitality
Harness the Lionbridge Lainguage Cloud to support your end-to-end localization and content lifecycle
Lainguage Cloud™ Platform
Connectivity
Translation Community
Workflow Technology
Smairt Content™
Smairt MT™
Smairt Data™
Language Quality
Analytics
SELECT LANGUAGE:
Last updated: May 11, 2021 9:30PM
The Changing EU Clinical Trial Landscape
May 27, 2014 was a pivotal day for clinical trials in the European Union (EU). On this date, the EU Clinical Trial Regulation (No. 536/2014) was officially published, replacing EU directive No. 2001/20/EC and revamping the way clinical trials are conducted in the region. For international trial sponsors as well as National Competent Authorities and EU member states, this regulation is a game-changer.
The new regulation harmonizes clinical trial requirements throughout the EU by establishing a new Clinical Trials Information System—a centralized portal and database developed and maintained by the European Medicines Agency (EMA) in collaboration with the European Commission and EU member states. Part of the information system will be open to the public subject to new transparency rules.
Find out more about our Life Sciences services.
Portal Creates Significant Challenges for Trial Sponsors
In our new whitepaper, we examine the upcoming regulation's impact on the clinical trial process for trial sponsors around the globe.
In this paper, you'll learn:
- How a new, centralized EU portal for clinical trials affects trial submissions and authorizations.
- How to establish efficient and reliable content translation in a region with 24 different official languages.
- How to respond to an increased drive for transparency, which puts the public and the patient in focus.
- How trial sponsors can meet challenges head-on with a centralized translation strategy.
Ready to learn more? Download the paper today.
